Zobrazeno 1 - 10
of 47
pro vyhledávání: '"M. R., Khaitov"'
Autor:
V. V. Makarevich, A. D. Taganovich, T. V. Mironova, I. P. Shilovskiy, M. R. Khaitov, A. G. Kadushkin
Publikováno v:
Сибирский научный медицинский журнал, Vol 44, Iss 5, Pp 35-45 (2024)
Allergic rhinitis (AR) occupies a leading position among the causes of morbidity throughout the world, to date, it has been diagnosed in 400 million people. In the formation and progression of AR, a significant role is assigned to cytokines associate
Externí odkaz:
https://doaj.org/article/05f6f03c9aac4269b029fa5f7e4e010b
Autor:
M. M. Kaganova, I. P. Shilovskiy, E. D. Timotievich, K. V. Yumashev, D. A. Gurskii, K. V. Vinogradova, M. V. Popova, M. R. Khaitov
Publikováno v:
Медицинская иммунология, Vol 26, Iss 5, Pp 1107-1114 (2024)
Allergic rhinitis (AR) is an inflammatory disease of the upper respiratory tract (nasal mucosa). AR affects up to 40% of the world’s population; in the Russian Federation, the incidence is 18% to 30%, depending on the region. Despite the fact that
Externí odkaz:
https://doaj.org/article/5cf5cec5475f4820943040c215bfd52c
Autor:
I. P. Shilovskiy, G. B. Pasikhov, V. V. Smirnov, I. A. Kofiadi, M. V. Popova, P. A. Strueva, M. R. Khaitov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 2, Pp 157-171 (2024)
INTRODUCTION. Small interfering RNAs (siRNAs) are among the most promising types of therapeutic nucleic acids aiming at the inhibition of pathogenetically relevant gene expression through the RNA interference mechanism. However, the limited bioavaila
Externí odkaz:
https://doaj.org/article/eb2d2fbfb84c4e88a2f8d5a7cea9133d
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 2, Pp 173-180 (2023)
Therapeutic monoclonal antibodies (mAbs), which are developed to treat many pathologies, including cancer, autoimmune and infectious diseases, are one of the fastest growing classes of medicinal products. Given the large number of mAbs in the pipelin
Externí odkaz:
https://doaj.org/article/57fbb0dd5c1b4995ba124095c6852e6c
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 2, Pp 124-141 (2022)
Diseases caused by Streptococcus pneumoniae, as well as antibiotic resistance of its serotypes, are the leading cause of death amongst children worldwide. To prevent pneumococcal infection, the population is immunised with conjugate vaccines containi
Externí odkaz:
https://doaj.org/article/759dd1a9ffe547f5b1d455824114c152
Publikováno v:
Медицинская иммунология, Vol 21, Iss 3, Pp 397-406 (2019)
Antiviral research has focused mainly on viral targets. However, cellular targets involved in the viral life cycle and antiviral response are becoming more attractive for research, providing a variety of opportunities for antiviral therapy. Toll-like
Externí odkaz:
https://doaj.org/article/5f386ea5083c42cda219ff3bd99499be
Publikováno v:
Бюллетень сибирской медицины, Vol 18, Iss 1, Pp 228-236 (2019)
Aim. In this study we aimed to investigate circulating blood cells during experimental virus-induced asthma exacerbation vs baseline.Materials and methods. Rhinovirus 16 (RV16) experimental infections were induced in RV16-seronegative moderate and mi
Externí odkaz:
https://doaj.org/article/d0957f63645f4209a1a149f8f864badf
Autor:
Yu. V. Zhernov, M. R. Khaitov
Publikováno v:
Бюллетень сибирской медицины, Vol 18, Iss 1, Pp 49-59 (2019)
Microbicides are antiseptic topical drugs that help directly or indirectly inhibit the penetration of an infectious agent into the human body, thereby preventing the sexual transmission of HIV-infection and other sexually transmitted diseases. Microb
Externí odkaz:
https://doaj.org/article/ea1512754d564536bd44f168cb0a1486
Publikováno v:
Медицинская иммунология, Vol 19, Iss 6, Pp 657-672 (2017)
Macrophages are among the most abundant cells of the respiratory tract, being characterized by their ability to have different phenotypes, depending on signals from the microenvironment (classically activated M1, alternatively activated M2). Despite
Externí odkaz:
https://doaj.org/article/67da7420628648cd9a90b5c419f10790
Autor:
A. M., Gileva, O. O., Koloskova, A. S., Nosova, L. I., Vishniakova, V. A., Simonova, L. A., Kurbanova, E. A., Egorenkov, V. V., Smirnov, U. A., Budanova, Yu L., Sebyakin, N. E., Suzina, M. R., Khaitov, E., Markvicheva
Publikováno v:
Journal of Biomedical Materials Research, Part B: Applied Biomaterials; Sep2023, Vol. 111 Issue 9, p1614-1628, 15p